I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Pharmacological ascorbate as a novel therapeutic strategy t..:
Amira Zaher
;
Laura M. Stephens
;
Ann M. Miller
...
https://www.frontiersin.org/articles/10.3389/fimmu.2022.989000/full. , 2022
Link:
https://doi.org/10.3389/fimmu.2022.989000
RT Journal T1 <Title>Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:ae800cab6bcd4188b2c0616a5d74bf80&Exemplar=1&LAN=DE A1 Amira Zaher A1 Laura M. Stephens A1 Ann M. Miller A1 Stacey M. Hartwig A1 Jeffrey M. Stolwijk A1 Michael S. Petronek A1 Zeb R. Zacharias A1 Thaddeus J. Wadas A1 Varun Monga A1 Joseph J. Cullen A1 Muhammad Furqan A1 Jon C. D. Houtman A1 Steven M. Varga A1 Douglas R. Spitz A1 Bryan G. Allen PB Frontiers Media S.A. YR 2022 K1 pharmacological ascorbate K1 immune regulation K1 anti-PD-1 K1 cancer immunotherapy K1 immune checkpoint inhibitors K1 antioxidant therapy K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/articles/10.3389/fimmu.2022.989000/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2022.989000 DO https://doi.org/10.3389/fimmu.2022.989000 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
